MedDataX Logo

Hospital Outcomes: Intervention in Moderately III Patients

NCT ID: NCT00256659

Last Updated: 2008-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

444 participants

Study Classification

INTERVENTIONAL

Study Start Date

1998-09-30

Study Completion Date

1999-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.

This is a randomized study which will compare the current Standard of Care in hospital to EARLY assessment and referrals with respect to social work services, rehabilitation, psychiatry, and nursing. In this study, the control group will receive the hospital support services provided under current system of delivery and allocation. The intervention group will not receive any new or different services not already provided to all patients at New York Presbyterian Hospital. The difference between the 2 groups will be the uniformity of screening to identify the needs of the patient in the respective area of social services, rehabilitation, psychiatric assistance, and nursing care, and the timeliness by which the referrals for support services will be placed.

Potential interventions: (In both control and experimental group)

1. Social work: Discharge planning (homecare, visiting nursing services, skilled nursing facility placement).
2. Rehabilitation: Physical Therapy (improve ADLs-activities of daily living).
3. Psychiatry: Diagnosis and Assistance in management of Depression.
4. Nursing: Prevention of in hospital falls and decubitus ulcer formation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Medical inpatients Social Work Physical therapy Occupational therapy Psychiatry Early intervention Iatrogenic complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early assessment and referral to ancillary care services vs. standard care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. All medical in-patients who are coded moderately ill with fair to poor function in the SIGNOUT program will be asked to participate in our study.
2. Patients who are able to provide verbal consent for their participation will be enrolled.

Exclusion Criteria

1. Any patient not coded in the SIGNOUT system as moderately ill with fair to poor function.
2. Patients who refuses not to participate in the study.
3. Patients who are unable to give written informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Weill Medical College of Cornell University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Weill Cornell Medical College

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary E Charlson, MD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

James Hollenberg, MD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Mark Pecker, MD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Sona Euster, MSW

Role: PRINCIPAL_INVESTIGATOR

Weill Medical Center of Cornell University

Delia Gorga, PhD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical Center of Cornell University

Mary Cooper, MD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York Presbyterian Hospital- Weill Medical Center

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9808003482

Identifier Type: -

Identifier Source: org_study_id